ClinicalTrials.Veeva

Menu

Extended Evening Fasting: Metabolic Health and Energy Balance

N

Nottingham Trent University

Status

Unknown

Conditions

Obesity

Treatments

Behavioral: Control
Behavioral: Extended Evening Fasting

Study type

Interventional

Funder types

Other

Identifiers

NCT04924517
WM_EEF_2021

Details and patient eligibility

About

This study will compare metabolic and feeding behaviour responses to 4 days of extended evening fasting vs. a control trial

Full description

Humans have evolved as a diurnal species, internally governed by the circadian system, which dictates our hormone regulation. 'Chrononutrition' is a sub-discipline which combines food timing with circadian physiology. The most popular method of time-restricted feeding in the UK is to skip breakfast. However, data from several meta-analysis have shown that skipping breakfast is associated with weight gain and insulin resistance, likely due to eating later into the evening/night and therefore, out of sync with our circadian rhythm. Recent research has shown that skipping dinner (evening fasting) has improved markers of cardio-metabolic health in clinical populations, although these are typically from longer-term studies. Despite these promising findings, it is not yet known whether these findings are population specific.

Therefore, the investigators are interested in examining the metabolic response pre and post intervention to see whether these promising findings can translate into a healthy population. Furthermore, the investigators will be monitoring subjective appetite, energy intake and expenditure to assess whether there is any short-term adaptation to a specific feeding window.

Enrollment

12 estimated patients

Sex

All

Ages

18 to 40 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Non-smokers.

    • Have maintained a stable weight for 6 months (self-reported).
    • No history of gastric, digestive, cardiovascular or renal disease (self reported).
    • Female specific: must be using a monophasic, low dose combined OCP (containing less than 50μg oestradiol and a synthetic progestin) OR females with regular menstrual cycles (self-reported).

Exclusion criteria

  • Severe food allergies, dislike or intolerance of study foods or drinks.

    • Currently undergoing a lifestyle intervention (structured diet or exercise)
    • Diagnosis of a condition or currently undergoing treatment therapy known to affect glucose or lipid metabolism (e.g., type-2 diabetes, taking statins), or contraindications to exercise.
    • Use of medication or supplements that may affect hormone concentrations.
    • Excessive alcohol consumption (>14 units/week).
    • Intensive training schedule (>10 hours/week).
    • Female specific: currently pregnant or breastfeeding, the use of any hormonal contraception, and the self-reporting of short (<24 d), long (>35 d), or irregular menstrual cycles.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

12 participants in 2 patient groups

Extended Evening Fasting
Experimental group
Description:
Participants will eat between 8am-4pm
Treatment:
Behavioral: Extended Evening Fasting
Control
Active Comparator group
Description:
Participants will eat between 8am-8pm
Treatment:
Behavioral: Control

Trial contacts and locations

1

Loading...

Central trial contact

David Clayton, PhD; William Mode, MRes

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems